Transvalvular Flow Rate is Associated With Mortality Rate and Lifetime Loss in Aortic Valve Stenosis: A Meta-Analysis of Reconstructed Time-to-Event Data.

Am J CardiolAug 3, 2026 (epub)
Clinical ResearchCardiology

Michel Pompeu Sá, Christian Ken Fukunaga, Iago T C Grillo et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis examined the association between transvalvular flow rate (TFR) and mortality in patients with aortic stenosis (AS), analyzing data from 9 studies with 6,494 patients. It found that low TFR was linked to a higher all-cause mortality rate, with a hazard ratio of 1.59 (95% CI 1.45 to 1.74, p < 0.001) and a lifetime loss of 2.3 years compared to normal TFR.

Key findings

  • At 8 years, survival was 34.1% in the low-TFR group versus 63% in the normal-TFR group.
  • Low TFR was associated with a hazard ratio of 1.59 for all-cause mortality.
  • The lifetime loss in the low-TFR group was 2.3 years compared to the normal-TFR group.

Why it matters

Understanding the prognostic implications of TFR in aortic stenosis can aid clinicians in risk stratification and management decisions, potentially improving patient outcomes through targeted interventions.

Source

Published in Am J Cardiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.